# CHEMBIO DIAGNOSTICS, INC.

CHEMBIO DIAGNOSTICS, INC. is a company headquartered in Hauppauge, NY, United States.

## Company overview

- **Legal name:** CHEMBIO DIAGNOSTICS, INC.
- **Former names in filing history:** Chembio Diagnostics Inc. (2004-06-04 to 2005-05-11); TRADING SOLUTIONS COM INC (1999-10-06 to 2004-06-07)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Hauppauge, NY, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001092662

## About

CHEMBIO DIAGNOSTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001092662, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-29, it reported annual revenue of USD 49,521,923; net income of USD -23,290,657; total assets of USD 62,611,405 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $49.5M (USD 49,521,923)
- **Net income:** -$23.3M (USD -23,290,657)
- **Total assets:** $62.6M (USD 62,611,405)
- **Cash and equivalents:** $18.2M (USD 18,178,985)
- **Operating cash flow:** -$12.7M (USD -12,693,953)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $47.8M (USD 47,818,452)
- **Net income:** -$33.9M (USD -33,903,529)
- **Total assets:** $73.3M (USD 73,252,195)
- **Cash and equivalents:** $28.8M (USD 28,772,892)
- **Operating cash flow:** -$30.9M (USD -30,885,716)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $32.5M (USD 32,470,197)
- **Net income:** -$25.5M (USD -25,521,328)
- **Total assets:** $64.9M (USD 64,892,014)
- **Cash and equivalents:** $23.1M (USD 23,066,301)
- **Operating cash flow:** -$18.9M (USD -18,887,238)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $34.5M (USD 34,464,032)
- **Net income:** -$13.7M (USD -13,675,129)
- **Total assets:** $55.7M (USD 55,728,964)
- **Cash and equivalents:** $18.3M (USD 18,271,352)
- **Operating cash flow:** -$9.1M (USD -9,055,506)

## Recent SEC filings

- Form SC 13D — filed 2023-05-01 — SC 13D
- Form 8-K — filed 2023-04-27 — period 2023-04-26 — 8-K
- Form SC 13D — filed 2023-04-07 — SC 13D
- Form 8-K — filed 2023-04-06 — period 2023-04-06 — 8-K
- Form 10-K — filed 2023-03-29 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-21 — period 2023-03-21 — 8-K
- Form 8-K — filed 2023-03-15 — period 2023-03-15 — 8-K
- Form 8-K — filed 2023-02-24 — period 2023-02-24 — 8-K
- Form 8-K — filed 2023-01-31 — period 2023-01-31 — FORM 8-K
- Form 8-K — filed 2022-11-04 — period 2022-11-03 — 8-K
- Form 10-Q — filed 2022-11-03 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-10-04 — period 2022-10-04 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/chembio-diagnostics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology